Creo Medical Group PLC (CREO) — Working Capital to Net Assets Ratio
Creo Medical Group PLC (CREO) has a Working Capital to Net Assets ratio of 32.4% as of December 2025. Working capital of GBX16.20 Million (current assets of GBX23.50 Million minus current liabilities of GBX7.30 Million) is measured against net assets of GBX50.00 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See CREO cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Creo Medical Group PLC Working Capital to Net Assets (2014–2025)
This chart shows how Creo Medical Group PLC's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2014 to 2025. As of December 2025, the ratio stands at 32.4%, reflecting working capital of GBX16.20 Million against net assets of GBX50.00 Million GBX. For the complete balance sheet picture, see Creo Medical Group PLC assets under control.
Annual Working Capital to Net Assets for Creo Medical Group PLC (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Creo Medical Group PLC from 2014 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check how resilient are Creo Medical Group PLC's assets to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 32.4% | GBX16.20 Million | GBX50.00 Million | GBX23.50 Million | GBX7.30 Million | ▼ -52.3 pp |
| 2024 | 84.7% | GBX35.90 Million | GBX42.40 Million | GBX56.40 Million | GBX20.50 Million | ▲ +37.8 pp |
| 2023 | 46.8% | GBX28.00 Million | GBX59.80 Million | GBX37.90 Million | GBX9.90 Million | ▲ +14.0 pp |
| 2022 | 32.8% | GBX16.20 Million | GBX49.40 Million | GBX33.69 Million | GBX17.48 Million | ▼ -23.7 pp |
| 2021 | 56.5% | GBX41.43 Million | GBX73.32 Million | GBX61.17 Million | GBX19.74 Million | ▼ -9.5 pp |
| 2020 | 66.0% | GBX41.44 Million | GBX62.81 Million | GBX59.47 Million | GBX18.03 Million | ▼ -32.0 pp |
| 2019 | 98.0% | GBX81.04 Million | GBX82.66 Million | GBX86.09 Million | GBX5.06 Million | ▼ -0.2 pp |
| 2018 | 98.2% | GBX46.87 Million | GBX47.71 Million | GBX48.51 Million | GBX1.64 Million | ▲ +4.5 pp |
| 2018 | 93.7% | GBX6.87 Million | GBX7.33 Million | GBX8.75 Million | GBX1.88 Million | ▼ -3.9 pp |
| 2017 | 97.6% | GBX14.30 Million | GBX14.65 Million | GBX15.77 Million | GBX1.47 Million | ▲ +13.5 pp |
| 2016 | 84.2% | GBX1.37 Million | GBX1.63 Million | GBX2.14 Million | GBX773.77K | ▼ -9.8 pp |
| 2016 | 94.0% | GBX3.03 Million | GBX3.22 Million | GBX3.54 Million | GBX512.38K | ▲ +10.8 pp |
| 2015 | 83.2% | GBX622.38K | GBX748.41K | GBX918.37K | GBX295.98K | ▼ -6.7 pp |
| 2014 | 89.9% | GBX1.24 Million | GBX1.37 Million | GBX1.49 Million | GBX250.20K | — |